Health Catalyst Inc

Health Catalyst insiders reveal CEO Albert Benjamin’s performance‑based PRSU award—showing leadership confidence and a bullish outlook for 2026 earnings.

Health Catalyst CEO’s recent sell‑to‑cover of 70,455 shares: why the move is routine, what it signals about insider confidence, and how to interpret the stock’s steep slide.

Health Catalyst’s CEO buys 930,000 RSUs and 38,833 PRSUs amid a 63 % yearly dip, signaling executive confidence and a strategy to drive future revenue growth.

Health Catalyst’s insider buying shows confidence amid low prices, suggesting a possible rebound if the company expands its data‑analytics platform beyond Utah.